Financial Performance - The company's operating revenue for Q1 2025 was ¥32,018,516.83, representing a 12.23% increase compared to ¥28,528,402.44 in the same period last year[4] - The net profit attributable to shareholders was a loss of ¥1,743,729.32, a decrease of 176.91% from a profit of ¥2,267,336.51 in the previous year[4] - Basic and diluted earnings per share were both -¥0.02, a decrease of 150.00% from ¥0.04 in the previous year[4] - Total operating revenue for Q1 2025 reached ¥32,018,516.83, an increase of 12.4% compared to ¥28,528,402.44 in Q1 2024[17] - Total operating costs for Q1 2025 were ¥39,165,477.41, up 20.7% from ¥32,416,937.26 in Q1 2024[17] - Net profit for Q1 2025 was a loss of ¥1,743,729.32, contrasting with a net profit of ¥2,267,336.51 in Q1 2024[19] - The basic and diluted earnings per share for Q1 2025 were both -¥0.02, compared to ¥0.04 in Q1 2024[19] Research and Development - The total R&D investment amounted to ¥18,953,310.84, which is a 58.62% increase from ¥11,948,567.43 in the same period last year[5] - R&D expenses accounted for 59.19% of operating revenue, up by 17.31 percentage points from 41.88% in the previous year[5] - R&D expenses increased significantly to ¥18,953,310.84 in Q1 2025, compared to ¥11,948,567.43 in Q1 2024, reflecting a growth of 58.7%[18] Cash Flow and Liquidity - The net cash flow from operating activities was a negative ¥16,400,388.27, an improvement from a negative ¥29,407,202.32 in the same period last year[4] - Cash inflow from investment activities in Q1 2025 was ¥155,863,666.58, with a net cash flow of ¥83,665,836.78 after outflows[21] - The company reported cash and cash equivalents of ¥415,900,209.48 as of March 31, 2025, an increase from ¥358,161,119.60 on December 31, 2024, reflecting a growth of approximately 16.3%[13] - The net increase in cash and cash equivalents for the period was $57,807,689.88, compared to $373,468,830.11 in the previous period[23] - The ending balance of cash and cash equivalents was $344,433,799.48, up from $567,541,468.11 in the previous period[23] - The beginning balance of cash and cash equivalents was $286,626,109.60, indicating a strong liquidity position[23] Assets and Liabilities - The total assets at the end of the reporting period were ¥841,321,928.61, a decrease of 2.17% from ¥859,989,449.60 at the end of the previous year[5] - Total assets decreased to ¥841,321,928.61 from ¥859,989,449.60, indicating a decline of approximately 2.2%[14] - Current liabilities decreased significantly from ¥45,265,467.33 to ¥27,765,394.67, a reduction of about 38.6%[14] - The company’s non-current assets increased to ¥86,990,980.30 from ¥84,372,249.32, representing a growth of approximately 3.8%[14] - The company reported a total liability of ¥31,747,293.00, down from ¥48,671,084.67 in the previous period[15] - Total equity attributable to shareholders was ¥809,574,635.61, slightly down from ¥811,318,364.93[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 5,440[9] - The company’s total equity remains stable, with no significant changes reported in the equity section of the balance sheet[14] Strategic Outlook - The company plans to continue expanding its market share and enhancing product competitiveness through increased sales and R&D expenditures[7] - The company has not disclosed any new product developments or market expansion strategies during the reporting period[12]
中创股份(688695) - 2025 Q1 - 季度财报